Waters Introduces Unrivaled Sensitivity and Speed to Benchtop HRMS with Xevo MRT P10 MS, Accelerating Multiomics Research
Delivers up to 20x improvement in MS/MS sensitivity and 2x faster acquisition speeds, enabling deeper biological insight for next-generation multiomics, therapeutic, and high-throughput workflows. Identifies up to 40% more lipids by LC‑MS/MS than...
GIGABYTE Debuts 40th Anniversary X870E and X870 AORUS INFINITY Series Motherboards at COMPUTEX 2026
TAIPEI, June 1, 2026 /PRNewswire/ -- GIGABYTE, the world's leading computer brand, debuts its 40th anniversary X870E and X870 AORUS INFINITY series motherboards at COMPUTEX 2026. Built for the latest AMD Ryzen™ 9950X3D2 processors, the series...
Waters Unveils Cyclic IMS P20 MS: The New Benchmark in Structural and Spatial Omics
>10x step-change in MS/MS sensitivity paired with multipass Cyclic™ Ion Mobility Spectrometry (IMS) reveals subtle biological differences for earlier, previously unattainable detection of disease signals. 50% extended upper mass range and...
Nota AI Works with NVIDIA to Expand Video AI Agent Market… Deployment of VSS-based NVA Spreads
Enhancing field responsiveness in transportation and industrial safety through NVIDIA VSS-based video search and summarization functions Proving the applicability of Generative AI video monitoring through cases of the Daejeon Regional Office of...
aulumu Launches G05 Pro Multi-Function Mag Kickstand
A compact magnetic stand engineered as an everyday urban utility toolkit SHENZHEN, China, June 1, 2026 /PRNewswire/ -- aulumu, the design-driven accessories brand renowned for blending futuristic aesthetics with practical engineering, today...
Drake International Launches Drake Force for Good Day, a Global Commitment to Building the Workforce of Tomorrow
On its 75th anniversary, the global talent management and workforce advisory firm declares that the organizations which will win the AI era are not those that automate fastest, but those that develop people best TORONTO, June 1, 2026 /PRNewswire/ --...
Biond Biologics and Guangzhou-Israel Biotechnology Fund ("GIBF") Announce Closing of $8 Million Investment and Collaboration
Biond Biologics and Guangzhou-Israel Biotechnology Fund (GIBF) Announce Strategic Investment and Joint Venture to Advance First-in-Class Oncology Programs in China MISGAV, Israel and GUANGZHOU, China, June 1, 2026 /PRNewswire/ -- Biond Biologics...
Ranok Therapeutics Announces Positive Interim Phase 1 Data Of Its KRAS G12D Inhibitor RNK08954 In Patients With KRAS G12D-Mutated Metastatic Non-Small Cell Lung Cancer Presented At ASCO 2026
Clinically Meaningful Overall Antitumor Activity, with ORR of 42.9% and DCR of 95.9% across all evaluated dose levels in heavily pretreated patients. Enhanced Clinical Activity at the Recommended Phase 2 Dose (RP2D), with ORR of 50% in patients who...